Literature DB >> 32129475

Inflammatory markers in saliva for diagnosis of sepsis of hospitalizes patients.

Luciana Freitas Galhardo1, Gilson Fernandes Ruivo1, Luciane Dias de Oliveira2, Graziele Parize3, Silvana Soléo Ferreira Dos Santos1, Debora Pallos3, Mariella Vieira Pereira Leão1,4.   

Abstract

BACKGROUND: Inflammatory/immunological serum markers are useful for the early detection of organ dysfunction, helping the diagnosis of sepsis. Although the detection of blood biomarkers is a standard practice, the use of noninvasive samples (eg saliva) would be beneficial. AIM: To investigate the saliva of hospitalized patients with and without sepsis and identify the levels of inflammatory markers such as C-reactive protein (CRP), procalcitonin (PCT), interleukin 6 (IL-6) and nitric oxide (NO).
METHODS: Saliva samples were collected from 26 patients in intensive care unit with diagnosis of sepsis and from 26 without sepsis (control). The levels of CRP were determined by using latex agglutination test, whereas those of procalcitonin and IL-6 by ELISA and NO by the Griess reaction.
RESULTS: Of 26 patients with sepsis, 14 were males (54%) with a mean age of 63.81 ± 3.48 years. The control group had the same distribution for gender, with mean age 65.04 ± 4.07 years. Sepsis group showed higher salivary concentrations of CRP, PCT, IL-6 and NO, with only levels of IL-6 being statistically different (P = .0001).
CONCLUSIONS: Patients with sepsis had significantly higher levels of IL-6 in their saliva, suggesting that this biological sample could be useful in the diagnosis of this condition.
© 2020 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  biomarkers; intensive care unit; saliva; sepsis

Mesh:

Substances:

Year:  2020        PMID: 32129475     DOI: 10.1111/eci.13219

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

Review 1.  Biomarker based biosensors: An opportunity for diagnosis of COVID-19.

Authors:  Reza Khaksarinejad; Zohreh Arabpour; Leila RezaKhani; Farzad Parvizpour; Yousef Rasmi
Journal:  Rev Med Virol       Date:  2022-04-27       Impact factor: 11.043

2.  Interleukin-17, a salivary biomarker for COVID-19 severity.

Authors:  Fatemeh Saheb Sharif-Askari; Narjes Saheb Sharif-Askari; Shirin Hafezi; Bushra Mdkhana; Hawra Ali Hussain Alsayed; Abdul Wahid Ansari; Bassam Mahboub; Adel M Zakeri; Mohamad-Hani Temsah; Walid Zahir; Qutayba Hamid; Rabih Halwani
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

3.  Evaluation of RNA Extraction-Free Method for Detection of SARS-CoV-2 in Salivary Samples for Mass Screening for COVID-19.

Authors:  Sally A Mahmoud; Subhashini Ganesan; Esra Ibrahim; Bhagyashree Thakre; Juliet G Teddy; Preety Raheja; Walid Z Abbas
Journal:  Biomed Res Int       Date:  2021-06-29       Impact factor: 3.411

4.  Salivary IL-6 Concentration Is Associated with Frailty Syndrome in Older Individuals.

Authors:  Pablo Gómez-Rubio; Isabel Trapero; Omar Cauli; Cristina Buigues
Journal:  Diagnostics (Basel)       Date:  2022-01-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.